Early research (Phase 1)Ended earlyNCT04800822What this trial is testingPF-07284892 in Participants With Advanced Solid TumorsWho this might be right forSolid Tumor Pfizer 53
Not applicableNot Yet RecruitingNCT07331805What this trial is testingConservative Management in Primary Spontaneous Pneumothorax: a Multicenter Randomized Non-inferiority StudyWho this might be right forPrimary Spontaneous Pneumothorax (PSP)Conservative Management (Active Observation) Corporacion Parc Tauli 436
Testing effectiveness (Phase 2)Looking for participantsNCT07480213What this trial is testingAdaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)Who this might be right forSmall Cell Lung Cancer (SCLC)Relapsed/Refractory SCLCSCLC, Extensive Stage Beijing Biotech 60
Early research (Phase 1)Study completedNCT02922764What this trial is testingRGX-104 in Patients With Advanced Lung & Endometrial CancerWho this might be right forEndometrial CancerEndometrial Cancer RecurrentLung Cancer Recurrent+3 more Inspirna, Inc. 146
Early research (Phase 1)Looking for participantsNCT03460977What this trial is testingMevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular LymphomaWho this might be right forMetastatic Castration Resistant Prostate Cancer (mCRPC)Small Cell Lung Cancer (SCLC)Follicular Lymphoma (FL) Pfizer 453
Not applicableLooking for participantsNCT07451405What this trial is testingThe Effect of Oscillation and Lung Expansion (OLE) Therapy in Prolonged Mechanical Ventilated Patients With Atelectasis Evaluated in Multiple MethodsWho this might be right forAtelectasis Capital Medical University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06128551What this trial is testingStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid TumorsWho this might be right forNon-Small Cell Lung Cancer (NSCLC)Colorectal CancerPancreatic Ductal Adenocarcinoma Revolution Medicines, Inc. 534
Early research (Phase 1)Study completedNCT04925284What this trial is testingStudy of XB002 in Subjects With Solid Tumors (JEWEL-101)Who this might be right forNon Small Cell Lung CancerCervical CancerSCCHN+8 more Exelixis 269
Early research (Phase 1)Ended earlyNCT02367352What this trial is testingAlisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsOvarian CancerSmall Cell Lung Cancer Millennium Pharmaceuticals, Inc. 9
Testing effectiveness (Phase 2)Looking for participantsNCT06840821What this trial is testingEvaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin ReceptorsWho this might be right forAdvanced Solid Tumors Mainline Biosciences (Shanghai) Co., Ltd 156
Early research (Phase 1)Ended earlyNCT06546553What this trial is testingLearn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.Who this might be right forNeoplasmsNon-small-cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+3 more Pfizer 10
Early research (Phase 1)Ended earlyNCT04999202What this trial is testingLearn How Safe the Study Drug BAY 2416964 (AhR Inhibitor) in Combination With the Treatment Pembrolizumab is, How This Combination Affects the Body, the Maximum Amount That Can be Given, How it Moves Into, Through and Out of the Body and Its Action Against Advanced Solid Cancers in AdultsWho this might be right forAdvanced Solid Tumors Bayer 47
Early research (Phase 1)Not Yet RecruitingNCT07617337What this trial is testingAQUA07 in Patients With ALK-Positive Non-Small Cell Lung CancerWho this might be right forALK Positive Non-small Cell Lung Cancer Chugai Pharmaceutical 102
Early research (Phase 1)UnknownNCT04667975What this trial is testingThe Purpose of Study is to Evaluate the Safety, Pharmacokinetics and Anti-tumor Effects of CKD-702 in Patients With Advanced or Metastatic Non-small Cell Lung Cancer Who Failed to Standard TherapyWho this might be right forNon-Small Cell Lung Cancer Chong Kun Dang Pharmaceutical 74
Early research (Phase 1)Looking for participantsNCT04678648What this trial is testingA Trial of RSC-1255 for Treatment of Patients With Advanced MalignanciesWho this might be right forAdvanced Malignant Solid NeoplasmRAS MutationLung Cancer+3 more RasCal Therapeutics, Inc. 134
Testing effectiveness (Phase 2)Active Not RecruitingNCT03830918What this trial is testingNiraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line ChemotherapyWho this might be right forAdvanced Malignant Solid NeoplasmExtensive Stage Lung Small Cell CarcinomaStage III Lung Cancer AJCC v8+6 more Jonsson Comprehensive Cancer Center 59
Testing effectiveness (Phase 2)Looking for participantsNCT05786924What this trial is testingPhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive MalignanciesWho this might be right forNon-small Cell Lung CancerHistiocytic NeoplasmHistiocytosis+29 more Institut de Recherches Internationales Servier 554
Testing effectiveness (Phase 2)Active Not RecruitingNCT04553133What this trial is testingPF-07104091 as a Single Agent and in Combination TherapyWho this might be right forSmall Cell Lung CancerOvarian CancerBreast Cancer Pfizer 157
Testing effectiveness (Phase 2)Study completedNCT03096782What this trial is testingUmbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or LymphomaWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Leukemia+19 more M.D. Anderson Cancer Center 6
Early research (Phase 1)Active Not RecruitingNCT05462717What this trial is testingDose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid TumorsWho this might be right forNon-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma+1 more Revolution Medicines, Inc. 222